These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 3802057)
41. Potent peroxisome proliferators inhibit beta-oxidation in the isolated perfused rat liver. Bojes HK; Thurman RG Toxicol Appl Pharmacol; 1996 Oct; 140(2):322-7. PubMed ID: 8887448 [TBL] [Abstract][Full Text] [Related]
42. Peroxisome proliferation due to di(2-ethylhexyl) phthalate (DEHP): species differences and possible mechanisms. Elcombe CR; Mitchell AM Environ Health Perspect; 1986 Dec; 70():211-9. PubMed ID: 3104023 [TBL] [Abstract][Full Text] [Related]
43. Association of persistent peroxisome proliferation and oxidative injury with hepatocarcinogenicity in female F-344 rats fed di(2-ethylhexyl)phthalate for 2 years. Cattley RC; Conway JG; Popp JA Cancer Lett; 1987 Dec; 38(1-2):15-22. PubMed ID: 3690505 [TBL] [Abstract][Full Text] [Related]
44. Results of peroxisome induction studies on tri(2-ethylhexyl)trimellitate and 2-ethylhexanol. Hodgson JR Toxicol Ind Health; 1987 Jun; 3(2):49-61. PubMed ID: 3617069 [TBL] [Abstract][Full Text] [Related]
45. Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: comparison of WY-14,643 to clofibric acid, nafenopin and LY171883. Eacho PI; Lanier TL; Brodhecker CA Carcinogenesis; 1991 Sep; 12(9):1557-61. PubMed ID: 1893515 [TBL] [Abstract][Full Text] [Related]
46. Lack of effect of furfural on unscheduled DNA synthesis in the in vivo rat and mouse hepatocyte DNA repair assays and in precision-cut human liver slices. Lake BG; Edwards AJ; Price RJ; Phillips BJ; Renwick AB; Beamand JA; Adams TB Food Chem Toxicol; 2001 Oct; 39(10):999-1011. PubMed ID: 11524138 [TBL] [Abstract][Full Text] [Related]
47. Measurement of unscheduled DNA synthesis and S-phase synthesis in rodent hepatocytes following in vivo treatment: testing of 24 compounds. Mirsalis JC; Tyson CK; Steinmetz KL; Loh EK; Hamilton CM; Bakke JP; Spalding JW Environ Mol Mutagen; 1989; 14(3):155-64. PubMed ID: 2792091 [TBL] [Abstract][Full Text] [Related]
48. Peroxisomal enzyme induction uncoupled from enhanced DNA synthesis in putative preneoplastic liver foci of rats treated with a single dose of the peroxisome proliferator nafenopin. Grasl-Kraupp B; Huber W; Timmermann-Trosiener I; Schulte-Hermann R Carcinogenesis; 1993 Nov; 14(11):2435-7. PubMed ID: 8242878 [TBL] [Abstract][Full Text] [Related]
49. On the mechanism of the hepatocarcinogenicity of peroxisome proliferators. Nilsson R; Beije B; Préat V; Erixon K; Ramel C Chem Biol Interact; 1991; 78(2):235-50. PubMed ID: 2040027 [TBL] [Abstract][Full Text] [Related]
50. Assessment of unscheduled and replicative DNA synthesis in hepatocytes treated in vivo and in vitro with unleaded gasoline or 2,2,4-trimethylpentane. Loury DJ; Smith-Oliver T; Strom S; Jirtle R; Michalopoulos G; Butterworth BE Toxicol Appl Pharmacol; 1986 Aug; 85(1):11-23. PubMed ID: 3726884 [TBL] [Abstract][Full Text] [Related]
51. Age-related susceptibility to the carcinogenic effect of the peroxisome proliferator WY-14,643 in rat liver. Cattley RC; Marsman DS; Popp JA Carcinogenesis; 1991 Mar; 12(3):469-73. PubMed ID: 1849052 [TBL] [Abstract][Full Text] [Related]
52. Mechanisms of peroxisome proliferator-induced DNA hypomethylation in rat liver. Pogribny IP; Tryndyak VP; Boureiko A; Melnyk S; Bagnyukova TV; Montgomery B; Rusyn I Mutat Res; 2008 Sep; 644(1-2):17-23. PubMed ID: 18639561 [TBL] [Abstract][Full Text] [Related]
53. Inhibition of intercellular communication of rat hepatocytes by nafenopin: involvement of protein kinase C. Leibold E; Greim H; Schwarz LR Carcinogenesis; 1994 Jun; 15(6):1265-9. PubMed ID: 8020165 [TBL] [Abstract][Full Text] [Related]
54. Absence of gamma-glutamyl transpeptidase activity in neoplastic lesions induced in the liver of male F-344 rats by di-(2-ethylhexyl)phthalate, a peroxisome proliferator. Rao MS; Usuda N; Subbarao V; Reddy JK Carcinogenesis; 1987 Sep; 8(9):1347-50. PubMed ID: 2887302 [TBL] [Abstract][Full Text] [Related]
55. Induction of replicative DNA synthesis and PPAR alpha-dependent gene transcription by Wy-14 643 in primary rat hepatocyte and non-parenchymal cell co-cultures. Karam WG; Ghanayem BI Carcinogenesis; 1997 Nov; 18(11):2077-83. PubMed ID: 9395205 [TBL] [Abstract][Full Text] [Related]
56. NMR spectroscopic analyses of liver phosphatidylcholine and phosphatidylethanolamine biosynthesis in rats exposed to peroxisome proliferators-A class of nongenotoxic hepatocarcinogens. Reo NV; Adinehzadeh M Toxicol Appl Pharmacol; 2000 Apr; 164(2):113-26. PubMed ID: 10764624 [TBL] [Abstract][Full Text] [Related]
57. Peroxisome proliferation and resistance to hydrogen peroxide in rat hepatocytes: is development of resistance an adaptation to cytotoxicity? Garberg P; Stenius U; Nilsson K; Högberg J Carcinogenesis; 1992 Oct; 13(10):1751-8. PubMed ID: 1423834 [TBL] [Abstract][Full Text] [Related]
58. Dietary glycine prevents increases in hepatocyte proliferation caused by the peroxisome proliferator WY-14,643. Rose ML; Germolec D; Arteel GE; Schoonhoven R; Thurman RG Chem Res Toxicol; 1997 Oct; 10(10):1198-204. PubMed ID: 9348444 [TBL] [Abstract][Full Text] [Related]
59. The potential role of chemically induced hyperplasia in the carcinogenic activity of the hypolipidemic carcinogens. Butterworth BE; Loury DJ; Smith-Oliver T; Cattley RC Toxicol Ind Health; 1987 Jun; 3(2):129-49. PubMed ID: 3303446 [TBL] [Abstract][Full Text] [Related]
60. Lack of hepatic promotional activity by the peroxisomal proliferating hepatocarcinogen di(2-ethylhexyl)phthalate. Popp JA; Garvey LK; Hamm TE; Swenberg JA Carcinogenesis; 1985 Jan; 6(1):141-4. PubMed ID: 2857115 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]